Our two oral ketamine products are branded Keticap®:
Oral Keticap® is an immediate release, abuse-deterrent, capsule formulation of therapeutic ketamine for the treatment of various mood disorders such as Treatment Resistant Depression (TRD) and bipolar depressions.
Keticap® has completed a Phase1 human trial which demonstrated the agent is safe and well tolerated at multiple dose levels where active drug concentrations and clinical activity are also observed.
We are now commencing additional trials – one for the treatment of bipolar depression, and additional studies in patients with other types of depression where the medicine is clinically indicated.
Keticap®-AD is intended to be the first standard prescription form of ketamine available for use as a routine and cost-effective oral medication to treat depression.